nodes	percent_of_prediction	percent_of_DWPC	metapath
Minaprine—SLC6A4—Circadian rythm related genes—SERPINE1—focal segmental glomerulosclerosis	0.00356	0.00356	CbGpPWpGaD
Minaprine—HTR2A—G alpha (q) signalling events—EDN1—focal segmental glomerulosclerosis	0.00355	0.00355	CbGpPWpGaD
Minaprine—CHRM1—G alpha (q) signalling events—EDN1—focal segmental glomerulosclerosis	0.00354	0.00354	CbGpPWpGaD
Minaprine—DRD1—Circadian rythm related genes—NOS2—focal segmental glomerulosclerosis	0.00342	0.00342	CbGpPWpGaD
Minaprine—HTR2C—G alpha (q) signalling events—AGT—focal segmental glomerulosclerosis	0.0034	0.0034	CbGpPWpGaD
Minaprine—HTR2B—Class A/1 (Rhodopsin-like receptors)—EDN1—focal segmental glomerulosclerosis	0.00336	0.00336	CbGpPWpGaD
Minaprine—ACHE—Metabolism of lipids and lipoproteins—LIPC—focal segmental glomerulosclerosis	0.00335	0.00335	CbGpPWpGaD
Minaprine—DRD2—GPCRs, Class A Rhodopsin-like—AGTR1—focal segmental glomerulosclerosis	0.00329	0.00329	CbGpPWpGaD
Minaprine—CHRM1—Regulation of Actin Cytoskeleton—FN1—focal segmental glomerulosclerosis	0.00325	0.00325	CbGpPWpGaD
Minaprine—HTR2A—GPCRs, Class A Rhodopsin-like—AGTR1—focal segmental glomerulosclerosis	0.00324	0.00324	CbGpPWpGaD
Minaprine—CHRM1—GPCRs, Class A Rhodopsin-like—AGTR1—focal segmental glomerulosclerosis	0.00322	0.00322	CbGpPWpGaD
Minaprine—HTR2C—Class A/1 (Rhodopsin-like receptors)—AGTR1—focal segmental glomerulosclerosis	0.0032	0.0032	CbGpPWpGaD
Minaprine—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—EDN1—focal segmental glomerulosclerosis	0.00318	0.00318	CbGpPWpGaD
Minaprine—DRD1—Class A/1 (Rhodopsin-like receptors)—EDN1—focal segmental glomerulosclerosis	0.00317	0.00317	CbGpPWpGaD
Minaprine—HTR2C—GPCR ligand binding—AGTR2—focal segmental glomerulosclerosis	0.00317	0.00317	CbGpPWpGaD
Minaprine—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—EDN1—focal segmental glomerulosclerosis	0.00316	0.00316	CbGpPWpGaD
Minaprine—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—AGT—focal segmental glomerulosclerosis	0.00304	0.00304	CbGpPWpGaD
Minaprine—HTR2B—GPCR ligand binding—AGTR1—focal segmental glomerulosclerosis	0.00302	0.00302	CbGpPWpGaD
Minaprine—ACHE—Metabolism of lipids and lipoproteins—CTGF—focal segmental glomerulosclerosis	0.00295	0.00295	CbGpPWpGaD
Minaprine—HTR2A—G alpha (q) signalling events—AGT—focal segmental glomerulosclerosis	0.00295	0.00295	CbGpPWpGaD
Minaprine—CHRM1—G alpha (q) signalling events—AGT—focal segmental glomerulosclerosis	0.00293	0.00293	CbGpPWpGaD
Minaprine—SLC6A4—NRF2 pathway—TGFB1—focal segmental glomerulosclerosis	0.0029	0.0029	CbGpPWpGaD
Minaprine—DRD1—Circadian rythm related genes—SERPINE1—focal segmental glomerulosclerosis	0.00288	0.00288	CbGpPWpGaD
Minaprine—DRD1—GPCR ligand binding—AGTR1—focal segmental glomerulosclerosis	0.00285	0.00285	CbGpPWpGaD
Minaprine—DRD2—Class A/1 (Rhodopsin-like receptors)—AGTR1—focal segmental glomerulosclerosis	0.00282	0.00282	CbGpPWpGaD
Minaprine—DRD2—GPCR ligand binding—AGTR2—focal segmental glomerulosclerosis	0.0028	0.0028	CbGpPWpGaD
Minaprine—HTR2B—Class A/1 (Rhodopsin-like receptors)—AGT—focal segmental glomerulosclerosis	0.00279	0.00279	CbGpPWpGaD
Minaprine—HTR2A—Class A/1 (Rhodopsin-like receptors)—AGTR1—focal segmental glomerulosclerosis	0.00278	0.00278	CbGpPWpGaD
Minaprine—CHRM1—Class A/1 (Rhodopsin-like receptors)—AGTR1—focal segmental glomerulosclerosis	0.00276	0.00276	CbGpPWpGaD
Minaprine—HTR2A—GPCR ligand binding—AGTR2—focal segmental glomerulosclerosis	0.00275	0.00275	CbGpPWpGaD
Minaprine—CHRM1—GPCR ligand binding—AGTR2—focal segmental glomerulosclerosis	0.00274	0.00274	CbGpPWpGaD
Minaprine—HTR2C—Class A/1 (Rhodopsin-like receptors)—EDN1—focal segmental glomerulosclerosis	0.00271	0.00271	CbGpPWpGaD
Minaprine—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—AGT—focal segmental glomerulosclerosis	0.00264	0.00264	CbGpPWpGaD
Minaprine—DRD1—Class A/1 (Rhodopsin-like receptors)—AGT—focal segmental glomerulosclerosis	0.00263	0.00263	CbGpPWpGaD
Minaprine—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—AGT—focal segmental glomerulosclerosis	0.00262	0.00262	CbGpPWpGaD
Minaprine—DRD2—Circadian rythm related genes—NOS2—focal segmental glomerulosclerosis	0.00258	0.00258	CbGpPWpGaD
Minaprine—HTR2B—GPCR ligand binding—EDN1—focal segmental glomerulosclerosis	0.00256	0.00256	CbGpPWpGaD
Minaprine—CHRM1—Circadian rythm related genes—NOS2—focal segmental glomerulosclerosis	0.00253	0.00253	CbGpPWpGaD
Minaprine—DRD2—G alpha (i) signalling events—AGT—focal segmental glomerulosclerosis	0.0025	0.0025	CbGpPWpGaD
Minaprine—HTR2C—GPCR ligand binding—AGTR1—focal segmental glomerulosclerosis	0.00244	0.00244	CbGpPWpGaD
Minaprine—DRD1—GPCR ligand binding—EDN1—focal segmental glomerulosclerosis	0.00241	0.00241	CbGpPWpGaD
Minaprine—DRD2—Class A/1 (Rhodopsin-like receptors)—EDN1—focal segmental glomerulosclerosis	0.00239	0.00239	CbGpPWpGaD
Minaprine—ACHE—Metabolism of proteins—ACE—focal segmental glomerulosclerosis	0.00239	0.00239	CbGpPWpGaD
Minaprine—HTR2A—Class A/1 (Rhodopsin-like receptors)—EDN1—focal segmental glomerulosclerosis	0.00235	0.00235	CbGpPWpGaD
Minaprine—CHRM1—Class A/1 (Rhodopsin-like receptors)—EDN1—focal segmental glomerulosclerosis	0.00234	0.00234	CbGpPWpGaD
Minaprine—HTR2C—Class A/1 (Rhodopsin-like receptors)—AGT—focal segmental glomerulosclerosis	0.00225	0.00225	CbGpPWpGaD
Minaprine—HTR2B—GPCR downstream signaling—TRPC6—focal segmental glomerulosclerosis	0.00223	0.00223	CbGpPWpGaD
Minaprine—HTR2B—GPCR downstream signaling—AGTR2—focal segmental glomerulosclerosis	0.00222	0.00222	CbGpPWpGaD
Minaprine—DRD2—Circadian rythm related genes—SERPINE1—focal segmental glomerulosclerosis	0.00218	0.00218	CbGpPWpGaD
Minaprine—DRD2—GPCR ligand binding—AGTR1—focal segmental glomerulosclerosis	0.00215	0.00215	CbGpPWpGaD
Minaprine—CHRM1—Circadian rythm related genes—SERPINE1—focal segmental glomerulosclerosis	0.00213	0.00213	CbGpPWpGaD
Minaprine—HTR2B—GPCR ligand binding—AGT—focal segmental glomerulosclerosis	0.00212	0.00212	CbGpPWpGaD
Minaprine—HTR2A—GPCR ligand binding—AGTR1—focal segmental glomerulosclerosis	0.00211	0.00211	CbGpPWpGaD
Minaprine—DRD1—GPCR downstream signaling—TRPC6—focal segmental glomerulosclerosis	0.0021	0.0021	CbGpPWpGaD
Minaprine—CHRM1—GPCR ligand binding—AGTR1—focal segmental glomerulosclerosis	0.0021	0.0021	CbGpPWpGaD
Minaprine—HTR2B—Signaling Pathways—COL4A4—focal segmental glomerulosclerosis	0.0021	0.0021	CbGpPWpGaD
Minaprine—DRD1—GPCR downstream signaling—AGTR2—focal segmental glomerulosclerosis	0.00209	0.00209	CbGpPWpGaD
Minaprine—HTR2C—GPCR ligand binding—EDN1—focal segmental glomerulosclerosis	0.00206	0.00206	CbGpPWpGaD
Minaprine—ACHE—Metabolism of lipids and lipoproteins—LPL—focal segmental glomerulosclerosis	0.00205	0.00205	CbGpPWpGaD
Minaprine—ACHE—Integrated Pancreatic Cancer Pathway—TGFB1—focal segmental glomerulosclerosis	0.00204	0.00204	CbGpPWpGaD
Minaprine—HTR2B—Signaling by GPCR—TRPC6—focal segmental glomerulosclerosis	0.00203	0.00203	CbGpPWpGaD
Minaprine—HTR2B—Signaling by GPCR—AGTR2—focal segmental glomerulosclerosis	0.00201	0.00201	CbGpPWpGaD
Minaprine—DRD1—GPCR ligand binding—AGT—focal segmental glomerulosclerosis	0.002	0.002	CbGpPWpGaD
Minaprine—DRD2—Class A/1 (Rhodopsin-like receptors)—AGT—focal segmental glomerulosclerosis	0.00199	0.00199	CbGpPWpGaD
Minaprine—DRD1—Signaling Pathways—COL4A4—focal segmental glomerulosclerosis	0.00198	0.00198	CbGpPWpGaD
Minaprine—HTR2A—Class A/1 (Rhodopsin-like receptors)—AGT—focal segmental glomerulosclerosis	0.00195	0.00195	CbGpPWpGaD
Minaprine—CHRM1—Class A/1 (Rhodopsin-like receptors)—AGT—focal segmental glomerulosclerosis	0.00194	0.00194	CbGpPWpGaD
Minaprine—HTR2B—Signaling Pathways—COL4A1—focal segmental glomerulosclerosis	0.00193	0.00193	CbGpPWpGaD
Minaprine—DRD1—Signaling by GPCR—TRPC6—focal segmental glomerulosclerosis	0.00191	0.00191	CbGpPWpGaD
Minaprine—DRD1—Signaling by GPCR—AGTR2—focal segmental glomerulosclerosis	0.0019	0.0019	CbGpPWpGaD
Minaprine—HTR2B—GPCR downstream signaling—GNAQ—focal segmental glomerulosclerosis	0.00187	0.00187	CbGpPWpGaD
Minaprine—DRD2—GPCR ligand binding—EDN1—focal segmental glomerulosclerosis	0.00182	0.00182	CbGpPWpGaD
Minaprine—DRD1—Signaling Pathways—COL4A1—focal segmental glomerulosclerosis	0.00182	0.00182	CbGpPWpGaD
Minaprine—HTR2C—GPCR downstream signaling—TRPC6—focal segmental glomerulosclerosis	0.0018	0.0018	CbGpPWpGaD
Minaprine—HTR2A—GPCR ligand binding—EDN1—focal segmental glomerulosclerosis	0.00179	0.00179	CbGpPWpGaD
Minaprine—HTR2C—GPCR downstream signaling—AGTR2—focal segmental glomerulosclerosis	0.00179	0.00179	CbGpPWpGaD
Minaprine—CHRM1—GPCR ligand binding—EDN1—focal segmental glomerulosclerosis	0.00178	0.00178	CbGpPWpGaD
Minaprine—DRD1—GPCR downstream signaling—GNAQ—focal segmental glomerulosclerosis	0.00176	0.00176	CbGpPWpGaD
Minaprine—ACHE—Metabolism of lipids and lipoproteins—AGT—focal segmental glomerulosclerosis	0.00175	0.00175	CbGpPWpGaD
Minaprine—HTR2C—GPCR ligand binding—AGT—focal segmental glomerulosclerosis	0.00171	0.00171	CbGpPWpGaD
Minaprine—HTR2B—GPCR downstream signaling—AGTR1—focal segmental glomerulosclerosis	0.00171	0.00171	CbGpPWpGaD
Minaprine—HTR2B—Signaling by GPCR—GNAQ—focal segmental glomerulosclerosis	0.00169	0.00169	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—COL4A4—focal segmental glomerulosclerosis	0.00169	0.00169	CbGpPWpGaD
Minaprine—HTR2C—Signaling by GPCR—TRPC6—focal segmental glomerulosclerosis	0.00163	0.00163	CbGpPWpGaD
Minaprine—HTR2B—Signaling Pathways—COL4A3—focal segmental glomerulosclerosis	0.00163	0.00163	CbGpPWpGaD
Minaprine—HTR2C—Signaling by GPCR—AGTR2—focal segmental glomerulosclerosis	0.00163	0.00163	CbGpPWpGaD
Minaprine—DRD1—GPCR downstream signaling—AGTR1—focal segmental glomerulosclerosis	0.00161	0.00161	CbGpPWpGaD
Minaprine—DRD1—Signaling by GPCR—GNAQ—focal segmental glomerulosclerosis	0.0016	0.0016	CbGpPWpGaD
Minaprine—DRD2—GPCR downstream signaling—TRPC6—focal segmental glomerulosclerosis	0.00159	0.00159	CbGpPWpGaD
Minaprine—DRD2—GPCR downstream signaling—AGTR2—focal segmental glomerulosclerosis	0.00158	0.00158	CbGpPWpGaD
Minaprine—HTR2A—GPCR downstream signaling—TRPC6—focal segmental glomerulosclerosis	0.00156	0.00156	CbGpPWpGaD
Minaprine—CHRM1—GPCR downstream signaling—TRPC6—focal segmental glomerulosclerosis	0.00155	0.00155	CbGpPWpGaD
Minaprine—HTR2A—GPCR downstream signaling—AGTR2—focal segmental glomerulosclerosis	0.00155	0.00155	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—COL4A1—focal segmental glomerulosclerosis	0.00155	0.00155	CbGpPWpGaD
Minaprine—HTR2B—Signaling by GPCR—AGTR1—focal segmental glomerulosclerosis	0.00155	0.00155	CbGpPWpGaD
Minaprine—CHRM1—GPCR downstream signaling—AGTR2—focal segmental glomerulosclerosis	0.00155	0.00155	CbGpPWpGaD
Minaprine—DRD1—Signaling Pathways—COL4A3—focal segmental glomerulosclerosis	0.00153	0.00153	CbGpPWpGaD
Minaprine—ACHE—Metabolism of proteins—AGT—focal segmental glomerulosclerosis	0.00151	0.00151	CbGpPWpGaD
Minaprine—DRD2—GPCR ligand binding—AGT—focal segmental glomerulosclerosis	0.00151	0.00151	CbGpPWpGaD
Minaprine—HTR2C—GPCR downstream signaling—GNAQ—focal segmental glomerulosclerosis	0.0015	0.0015	CbGpPWpGaD
Minaprine—ACHE—Metabolism—LIPC—focal segmental glomerulosclerosis	0.00149	0.00149	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—COL4A4—focal segmental glomerulosclerosis	0.00149	0.00149	CbGpPWpGaD
Minaprine—HTR2A—GPCR ligand binding—AGT—focal segmental glomerulosclerosis	0.00149	0.00149	CbGpPWpGaD
Minaprine—CHRM1—GPCR ligand binding—AGT—focal segmental glomerulosclerosis	0.00148	0.00148	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—COL4A4—focal segmental glomerulosclerosis	0.00147	0.00147	CbGpPWpGaD
Minaprine—DRD1—Signaling by GPCR—AGTR1—focal segmental glomerulosclerosis	0.00146	0.00146	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—COL4A4—focal segmental glomerulosclerosis	0.00146	0.00146	CbGpPWpGaD
Minaprine—HTR2B—GPCR downstream signaling—EDN1—focal segmental glomerulosclerosis	0.00145	0.00145	CbGpPWpGaD
Minaprine—DRD2—Signaling by GPCR—TRPC6—focal segmental glomerulosclerosis	0.00144	0.00144	CbGpPWpGaD
Minaprine—DRD2—Signaling by GPCR—AGTR2—focal segmental glomerulosclerosis	0.00143	0.00143	CbGpPWpGaD
Minaprine—HTR2A—Signaling by GPCR—TRPC6—focal segmental glomerulosclerosis	0.00142	0.00142	CbGpPWpGaD
Minaprine—CHRM1—Signaling by GPCR—TRPC6—focal segmental glomerulosclerosis	0.00141	0.00141	CbGpPWpGaD
Minaprine—HTR2A—Signaling by GPCR—AGTR2—focal segmental glomerulosclerosis	0.00141	0.00141	CbGpPWpGaD
Minaprine—MAOA—Metabolism—LIPC—focal segmental glomerulosclerosis	0.00141	0.00141	CbGpPWpGaD
Minaprine—CHRM1—Signaling by GPCR—AGTR2—focal segmental glomerulosclerosis	0.0014	0.0014	CbGpPWpGaD
Minaprine—HTR2C—GPCR downstream signaling—AGTR1—focal segmental glomerulosclerosis	0.00138	0.00138	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—COL4A1—focal segmental glomerulosclerosis	0.00137	0.00137	CbGpPWpGaD
Minaprine—HTR2C—Signaling by GPCR—GNAQ—focal segmental glomerulosclerosis	0.00137	0.00137	CbGpPWpGaD
Minaprine—DRD1—GPCR downstream signaling—EDN1—focal segmental glomerulosclerosis	0.00136	0.00136	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—COL4A1—focal segmental glomerulosclerosis	0.00135	0.00135	CbGpPWpGaD
Minaprine—ACHE—Metabolism of lipids and lipoproteins—ALB—focal segmental glomerulosclerosis	0.00134	0.00134	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—COL4A1—focal segmental glomerulosclerosis	0.00134	0.00134	CbGpPWpGaD
Minaprine—DRD2—GPCR downstream signaling—GNAQ—focal segmental glomerulosclerosis	0.00133	0.00133	CbGpPWpGaD
Minaprine—ACHE—Metabolism—CTGF—focal segmental glomerulosclerosis	0.00132	0.00132	CbGpPWpGaD
Minaprine—HTR2B—Signaling by GPCR—EDN1—focal segmental glomerulosclerosis	0.00131	0.00131	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—COL4A3—focal segmental glomerulosclerosis	0.00131	0.00131	CbGpPWpGaD
Minaprine—HTR2A—GPCR downstream signaling—GNAQ—focal segmental glomerulosclerosis	0.00131	0.00131	CbGpPWpGaD
Minaprine—CHRM1—GPCR downstream signaling—GNAQ—focal segmental glomerulosclerosis	0.0013	0.0013	CbGpPWpGaD
Minaprine—HTR2C—Signaling by GPCR—AGTR1—focal segmental glomerulosclerosis	0.00125	0.00125	CbGpPWpGaD
Minaprine—MAOA—Metabolism—CTGF—focal segmental glomerulosclerosis	0.00124	0.00124	CbGpPWpGaD
Minaprine—DRD1—Signaling by GPCR—EDN1—focal segmental glomerulosclerosis	0.00124	0.00124	CbGpPWpGaD
Minaprine—DRD2—GPCR downstream signaling—AGTR1—focal segmental glomerulosclerosis	0.00121	0.00121	CbGpPWpGaD
Minaprine—ACHE—Metabolism—GNAQ—focal segmental glomerulosclerosis	0.00121	0.00121	CbGpPWpGaD
Minaprine—DRD2—Signaling by GPCR—GNAQ—focal segmental glomerulosclerosis	0.00121	0.00121	CbGpPWpGaD
Minaprine—HTR2B—GPCR downstream signaling—AGT—focal segmental glomerulosclerosis	0.0012	0.0012	CbGpPWpGaD
Minaprine—HTR2B—Signaling Pathways—TRPC6—focal segmental glomerulosclerosis	0.0012	0.0012	CbGpPWpGaD
Minaprine—HTR2A—GPCR downstream signaling—AGTR1—focal segmental glomerulosclerosis	0.0012	0.0012	CbGpPWpGaD
Minaprine—HTR2B—Signaling Pathways—AGTR2—focal segmental glomerulosclerosis	0.00119	0.00119	CbGpPWpGaD
Minaprine—CHRM1—GPCR downstream signaling—AGTR1—focal segmental glomerulosclerosis	0.00119	0.00119	CbGpPWpGaD
Minaprine—HTR2A—Signaling by GPCR—GNAQ—focal segmental glomerulosclerosis	0.00119	0.00119	CbGpPWpGaD
Minaprine—ACHE—Metabolism of proteins—MMP2—focal segmental glomerulosclerosis	0.00119	0.00119	CbGpPWpGaD
Minaprine—CHRM1—Signaling by GPCR—GNAQ—focal segmental glomerulosclerosis	0.00118	0.00118	CbGpPWpGaD
Minaprine—HTR2C—GPCR downstream signaling—EDN1—focal segmental glomerulosclerosis	0.00117	0.00117	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—COL4A3—focal segmental glomerulosclerosis	0.00116	0.00116	CbGpPWpGaD
Minaprine—MAOA—Metabolism—GNAQ—focal segmental glomerulosclerosis	0.00114	0.00114	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—COL4A3—focal segmental glomerulosclerosis	0.00114	0.00114	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—COL4A3—focal segmental glomerulosclerosis	0.00113	0.00113	CbGpPWpGaD
Minaprine—DRD1—GPCR downstream signaling—AGT—focal segmental glomerulosclerosis	0.00113	0.00113	CbGpPWpGaD
Minaprine—DRD1—Signaling Pathways—TRPC6—focal segmental glomerulosclerosis	0.00113	0.00113	CbGpPWpGaD
Minaprine—DRD1—Signaling Pathways—AGTR2—focal segmental glomerulosclerosis	0.00112	0.00112	CbGpPWpGaD
Minaprine—DRD2—Signaling by GPCR—AGTR1—focal segmental glomerulosclerosis	0.0011	0.0011	CbGpPWpGaD
Minaprine—HTR2B—Signaling by GPCR—AGT—focal segmental glomerulosclerosis	0.00109	0.00109	CbGpPWpGaD
Minaprine—HTR2A—Signaling by GPCR—AGTR1—focal segmental glomerulosclerosis	0.00109	0.00109	CbGpPWpGaD
Minaprine—CHRM1—Signaling by GPCR—AGTR1—focal segmental glomerulosclerosis	0.00108	0.00108	CbGpPWpGaD
Minaprine—HTR2C—Signaling by GPCR—EDN1—focal segmental glomerulosclerosis	0.00106	0.00106	CbGpPWpGaD
Minaprine—DRD2—GPCR downstream signaling—EDN1—focal segmental glomerulosclerosis	0.00103	0.00103	CbGpPWpGaD
Minaprine—DRD1—Signaling by GPCR—AGT—focal segmental glomerulosclerosis	0.00103	0.00103	CbGpPWpGaD
Minaprine—HTR2A—GPCR downstream signaling—EDN1—focal segmental glomerulosclerosis	0.00101	0.00101	CbGpPWpGaD
Minaprine—CHRM1—GPCR downstream signaling—EDN1—focal segmental glomerulosclerosis	0.00101	0.00101	CbGpPWpGaD
Minaprine—HTR2B—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	0.001	0.001	CbGpPWpGaD
Minaprine—HTR2C—GPCR downstream signaling—AGT—focal segmental glomerulosclerosis	0.000968	0.000968	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—TRPC6—focal segmental glomerulosclerosis	0.000966	0.000966	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—AGTR2—focal segmental glomerulosclerosis	0.00096	0.00096	CbGpPWpGaD
Minaprine—DRD1—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	0.000944	0.000944	CbGpPWpGaD
Minaprine—DRD2—Signaling by GPCR—EDN1—focal segmental glomerulosclerosis	0.000935	0.000935	CbGpPWpGaD
Minaprine—HTR2A—Signaling by GPCR—EDN1—focal segmental glomerulosclerosis	0.00092	0.00092	CbGpPWpGaD
Minaprine—CHRM1—Signaling by GPCR—EDN1—focal segmental glomerulosclerosis	0.000915	0.000915	CbGpPWpGaD
Minaprine—HTR2B—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	0.000915	0.000915	CbGpPWpGaD
Minaprine—ACHE—Metabolism—LPL—focal segmental glomerulosclerosis	0.000912	0.000912	CbGpPWpGaD
Minaprine—HTR2C—Signaling by GPCR—AGT—focal segmental glomerulosclerosis	0.000879	0.000879	CbGpPWpGaD
Minaprine—DRD1—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	0.000863	0.000863	CbGpPWpGaD
Minaprine—MAOA—Metabolism—LPL—focal segmental glomerulosclerosis	0.000859	0.000859	CbGpPWpGaD
Minaprine—DRD2—GPCR downstream signaling—AGT—focal segmental glomerulosclerosis	0.000855	0.000855	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—TRPC6—focal segmental glomerulosclerosis	0.000852	0.000852	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—AGTR2—focal segmental glomerulosclerosis	0.000847	0.000847	CbGpPWpGaD
Minaprine—HTR2A—GPCR downstream signaling—AGT—focal segmental glomerulosclerosis	0.000841	0.000841	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—TRPC6—focal segmental glomerulosclerosis	0.000839	0.000839	CbGpPWpGaD
Minaprine—CHRM1—GPCR downstream signaling—AGT—focal segmental glomerulosclerosis	0.000836	0.000836	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—TRPC6—focal segmental glomerulosclerosis	0.000834	0.000834	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—AGTR2—focal segmental glomerulosclerosis	0.000834	0.000834	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—AGTR2—focal segmental glomerulosclerosis	0.000829	0.000829	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	0.000807	0.000807	CbGpPWpGaD
Minaprine—ACHE—Metabolism—AGT—focal segmental glomerulosclerosis	0.00078	0.00078	CbGpPWpGaD
Minaprine—DRD2—Signaling by GPCR—AGT—focal segmental glomerulosclerosis	0.000776	0.000776	CbGpPWpGaD
Minaprine—HTR2B—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	0.000776	0.000776	CbGpPWpGaD
Minaprine—HTR2A—Signaling by GPCR—AGT—focal segmental glomerulosclerosis	0.000764	0.000764	CbGpPWpGaD
Minaprine—CHRM1—Signaling by GPCR—AGT—focal segmental glomerulosclerosis	0.00076	0.00076	CbGpPWpGaD
Minaprine—HTR2B—Signaling Pathways—LPL—focal segmental glomerulosclerosis	0.000753	0.000753	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	0.000738	0.000738	CbGpPWpGaD
Minaprine—MAOA—Metabolism—AGT—focal segmental glomerulosclerosis	0.000735	0.000735	CbGpPWpGaD
Minaprine—DRD1—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	0.000732	0.000732	CbGpPWpGaD
Minaprine—HTR2B—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	0.000713	0.000713	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	0.000712	0.000712	CbGpPWpGaD
Minaprine—DRD1—Signaling Pathways—LPL—focal segmental glomerulosclerosis	0.00071	0.00071	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	0.000701	0.000701	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	0.000697	0.000697	CbGpPWpGaD
Minaprine—DRD1—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	0.000672	0.000672	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	0.000652	0.000652	CbGpPWpGaD
Minaprine—HTR2B—Signaling Pathways—AGT—focal segmental glomerulosclerosis	0.000644	0.000644	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	0.000641	0.000641	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	0.000638	0.000638	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	0.000626	0.000626	CbGpPWpGaD
Minaprine—CYP2D6—Metabolism—LIPC—focal segmental glomerulosclerosis	0.000613	0.000613	CbGpPWpGaD
Minaprine—DRD1—Signaling Pathways—AGT—focal segmental glomerulosclerosis	0.000607	0.000607	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—LPL—focal segmental glomerulosclerosis	0.000607	0.000607	CbGpPWpGaD
Minaprine—ACHE—Metabolism—ALB—focal segmental glomerulosclerosis	0.000598	0.000598	CbGpPWpGaD
Minaprine—HTR2B—Signaling Pathways—FN1—focal segmental glomerulosclerosis	0.000595	0.000595	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	0.000575	0.000575	CbGpPWpGaD
Minaprine—MAOA—Metabolism—ALB—focal segmental glomerulosclerosis	0.000564	0.000564	CbGpPWpGaD
Minaprine—DRD1—Signaling Pathways—FN1—focal segmental glomerulosclerosis	0.000561	0.000561	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	0.000552	0.000552	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	0.000544	0.000544	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	0.000541	0.000541	CbGpPWpGaD
Minaprine—CYP2D6—Metabolism—CTGF—focal segmental glomerulosclerosis	0.000539	0.000539	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—LPL—focal segmental glomerulosclerosis	0.000536	0.000536	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—LPL—focal segmental glomerulosclerosis	0.000527	0.000527	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—LPL—focal segmental glomerulosclerosis	0.000525	0.000525	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—AGT—focal segmental glomerulosclerosis	0.00052	0.00052	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	0.000508	0.000508	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	0.000499	0.000499	CbGpPWpGaD
Minaprine—CYP2D6—Metabolism—GNAQ—focal segmental glomerulosclerosis	0.000497	0.000497	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	0.000497	0.000497	CbGpPWpGaD
Minaprine—HTR2B—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	0.000495	0.000495	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—FN1—focal segmental glomerulosclerosis	0.00048	0.00048	CbGpPWpGaD
Minaprine—DRD1—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	0.000467	0.000467	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—AGT—focal segmental glomerulosclerosis	0.000459	0.000459	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—AGT—focal segmental glomerulosclerosis	0.000451	0.000451	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—AGT—focal segmental glomerulosclerosis	0.000449	0.000449	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—FN1—focal segmental glomerulosclerosis	0.000424	0.000424	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—FN1—focal segmental glomerulosclerosis	0.000417	0.000417	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—FN1—focal segmental glomerulosclerosis	0.000415	0.000415	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	0.000399	0.000399	CbGpPWpGaD
Minaprine—HTR2B—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	0.000379	0.000379	CbGpPWpGaD
Minaprine—CYP2D6—Metabolism—LPL—focal segmental glomerulosclerosis	0.000374	0.000374	CbGpPWpGaD
Minaprine—DRD1—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	0.000358	0.000358	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	0.000353	0.000353	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	0.000347	0.000347	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	0.000345	0.000345	CbGpPWpGaD
Minaprine—CYP2D6—Metabolism—AGT—focal segmental glomerulosclerosis	0.00032	0.00032	CbGpPWpGaD
Minaprine—HTR2B—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	0.000313	0.000313	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	0.000306	0.000306	CbGpPWpGaD
Minaprine—DRD1—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	0.000295	0.000295	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	0.00027	0.00027	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	0.000266	0.000266	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	0.000264	0.000264	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	0.000252	0.000252	CbGpPWpGaD
Minaprine—CYP2D6—Metabolism—ALB—focal segmental glomerulosclerosis	0.000245	0.000245	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	0.000223	0.000223	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	0.000219	0.000219	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	0.000218	0.000218	CbGpPWpGaD
